Wird geladen...
Advances in Diabetes for the Millennium: Diabetes and Cholesterol
The development of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors has made it possible to significantly lower cholesterol and low-density lipoprotein (LDL) levels. A moderate reduction of LDL levels has resulted in substantial decreases on the order of 30% to 40% in cardiovascu...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Medscape
2004
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1474830/ https://ncbi.nlm.nih.gov/pubmed/15647710 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|